Sigbjørn Smeland

Author information from the last article

Sigbjørn Smeland er onkolog, klinikkleder ved Kreftklinikken ved Oslo universitetssykehus og professor ved Universitetet i Oslo.

Articles by Sigbjørn Smeland

Should calculation of chemotherapy dosage for bowel cancer be based on body composition?

Ane Sørlie Kværner,
Helene Harnæs,
Dena Helene Alavi,
Linnea Bärebring,
Hege Berg Henriksen,
Marianne Grønlie Guren,
Peter Mæhre Lauritzen,
Heidi Beate Eggesbø,
Gro Wiedswang,
Sigbjørn Smeland,
Rune Blomhoff

19.05.2020: Colorectal cancer is the most prevalent form of cancer among Norwegian men and woman, with 4 428 new cases in 2018 (1). Since the 1940s there has been a doubling of incidence, but also of five-year relative survival, which is now at about 70 % (1). Higher survival is attributed partly to new...